A Retrospective Analysis of Rituximab Treatment for B Cell Depletion in Different Pediatric Indications

Background: Rituximab (RTX) is used in cancer therapy as well as in the treatment of autoimmune diseases and alloimmune responses after transplantation. It depletes the disease-causing B cells by binding to the CD (cluster of differentiation) 20 antigen. We evaluate different pediatric treatment pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wennmann, Merlin, Kathemann, Simone, Kampmann, Kristina, Ohlsson, Sinja, Büscher, Anja, Holzinger, Dirk, Della Marina, Adela, Lainka, Elke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669827/
https://www.ncbi.nlm.nih.gov/pubmed/34917554
http://dx.doi.org/10.3389/fped.2021.651323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669827/
https://www.ncbi.nlm.nih.gov/pubmed/34917554
http://dx.doi.org/10.3389/fped.2021.651323

Ejemplares similares